News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Analyst recommends buying ExxonMobil at $159.46 citing a 2.58% dividend yield and 20.5x P/E.
  • Analyst pins Exxon upside at $176.41 with 52-week support near $108.
  • Exxon benefits from operational leverage to rising oil prices.
  • Exxon is continuing capital returns.
  • Moneymax partners with EastWest to expand digital personal loan access in the Philippines.
  • The partnership will broaden loan options available on Moneymax.
  • The tie-up supports EastWest's digital customer acquisition in the Philippine consumer lending market.

Latest Articles

AMC: Trade the News, But Watch the Share Count

AMC: Trade the News, But Watch the Share Count

AMC is trading at $2.66 with clear operational momentum from stronger attendance and a cleaner debt profile after recent refinancing. The stock can rally near-term, but the dominant risk remains share issuance. This trade sets a defined entry, stop and target while emphasizing active monitoring of outstanding shares and any new equity deals.

U.S. Firms Report Growing Wave of AI-Linked Cyber Intrusions and Ransomware

U.S. Firms Report Growing Wave of AI-Linked Cyber Intrusions and Ransomware

Companies across multiple U.S. sectors have disclosed a steady stream of cyber incidents this year, many involving AI-driven tools, ransomware groups or social-engineering attacks. The White House has said it launched a coordination group last month to help AI developers and critical infrastructure operators share vulnerability information, but it …

Rail Vision Delivers Strong Commercial Momentum in First Half of 2026 with Revenue Exceeding $1 Million

Rail Vision Delivers Strong Commercial Momentum in First Half of 2026 with Revenue Exceeding $1 Million

Rail Vision Ltd. achieved significant commercial momentum in the first half of 2026, with revenues surpassing $1 million, a 328% increase from the prior year period. Key achievements include integration of its ShuntingYard technology into Railserve’s YardGUARD system in the U.S., successful field testing with Israel Railways, and continued global b…

Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026

Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026

Trevi Therapeutics, a clinical-stage biopharmaceutical company listed on Nasdaq (TRVI), announced acceptance of two abstracts for presentations at the ERS Congress 2026 in Barcelona. The presentations focus on quality-of-life outcomes from their Phase 2b CORAL and Phase 2a RIVER trials evaluating their investigational therapy, oral nalbuphine exten…

BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM

BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM

BridgeBio Pharma has initiated dosing of the first participant in ASCEND-ATTR, a Phase 3b/4 clinical study designed to assess the long-term effects of acoramidis, an oral transthyretin stabilizer, on cardiac structure, function, and amyloid burden in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Building on prior Phase 3 ATTRibute-C…

Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2026 Results

Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2026 Results

Abercrombie & Fitch Co. announced record net sales of $1.3 billion for Q2 fiscal 2026, marking the 15th consecutive quarter of growth with sales increases across all regions, led by an 8% rise in the Abercrombie brand. Operating margin reached 20%, and EPS was $4.17, outperforming prior outlook partly due to a $100 million IEEPA tariff refund benef…

Nexera Technologies: Subsidiary Fort Technology Closes Acquisition of Majority Stake in Logia USA to Fuel the Future of Data Centers

Nexera Technologies: Subsidiary Fort Technology Closes Acquisition of Majority Stake in Logia USA to Fuel the Future of Data Centers

Nexera Technologies announces that its majority-owned subsidiary Fort Technology has completed the acquisition of 50.1% of Logia USA, a company specializing in advanced fuel integrity solutions for data centers and other critical facilities in the US. This acquisition positions Fort Technology to capitalize on the growing data center market expecte…

Ondas: Real Top-Line Momentum — Trade It With Tight Risk Control

Ondas: Real Top-Line Momentum — Trade It With Tight Risk Control

Ondas (ONDS) is growing fast: recent contract wins and an acquisition lift 2026 revenue targets well into the hundreds of millions, yet the company remains unprofitable and cash flow negative. For traders willing to accept volatility, a defined long trade with a clear stop and target offers attractive asymmetric upside while limiting downside if ex…

Sezzle Anywhere + Sezzle Cash: Hidden Operating Leverage, Visible Upside

Sezzle Anywhere + Sezzle Cash: Hidden Operating Leverage, Visible Upside

Sezzle's merchant-facing Sezzle Anywhere checkout and consumer-facing Sezzle Cash product create a path to disproportionate EBITDA growth as volumes scale. The market appears to be underestimating operating leverage from higher take rates, fixed-cost absorption, and cross-sell between products. This trade targets the re-rating that should follow ac…

Arteris Building a Base Near $23 — Setup for a Mid-Stage Breakout

Arteris Building a Base Near $23 — Setup for a Mid-Stage Breakout

Arteris (AIP) has pulled back from its 52-week highs and is carving a consolidation base around $23. The company's steady wins in automotive and cybersecurity IP, plus a recent acquisition and expanded Arm partnership, give a fundamental backdrop for a swing trade. Valuation is lofty vs. current profitability, so the trade is price-action driven wi…

Ligand to Participate in September Investor Conferences

Ligand to Participate in September Investor Conferences

Ligand Pharmaceuticals announced that its senior management team will participate in key investor conferences in September 2026, including the Wells Fargo Healthcare Conference, Citi Biopharma Back to School Conference, and H.C. Wainwright Global Investment Conference. Management will conduct fireside chats and one-on-one meetings to discuss the co…